跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,849 条关于
“tremelimumab-actl”
全部
1,849
临床试验
1,573
药物
158
机构
3
资讯
115
2年前
Imfinzi and Imjudo Combo Shows Unprecedented Survival in Liver Cancer
2年前
Durvalumab Demonstrates Improved Survival in Liver and Bladder Cancers
去年
Novel Therapies Transform Treatment Landscape for Liver and Biliary Tract Cancers
去年
FDA Issues Second Rejection for Rivoceranib/Camrelizumab Combination in Unresectable Liver Cancer
5年前
Triplet Therapy of Durvalumab, Tremelimumab, and Paclitaxel Halted in Biliary Tract Cancer Trial Due to Safety Concerns
去年
AstraZeneca's Durvalumab-Tremelimumab Combination Approved for Liver Cancer Treatment in India
去年
CDSCO Approves AstraZeneca's Protocol Amendments for Durvalumab-Tremelimumab Combination in Advanced Liver Cancer
2个月前
HIMALAYA Trial: Tremelimumab Plus Durvalumab Establishes New Frontline Standard in Unresectable Hepatocellular Carcinoma
2年前
STRIDE Regimen Shows Unprecedented 5-Year Survival in Unresectable Hepatocellular Carcinoma
去年
Real-World Safety Analysis Reveals Complex Toxicity Profile of Tremelimumab-Durvalumab Combination in Hepatocellular Carcinoma
第 1 页,共 12 页
上一页
下一页